Transrectal ultrasound-guided transperineal prostate biopsy (TPPBx) has largely replaced transrectal prostate biopsy (TRUS+Bx) as the procedure of choice by patients with high prostate-specific antigen (PSA) due to the high infection rates of TRUS+Bx. The gene discussed is KLK3; the disease is infection.